19 May 2013
Keywords: novartis, launches, enact, program, swiss, drug, major
Article | 12 June 2006
Swiss drug major Novartis has launched the ENACT (Expanding Nilotinib Access in Clinical Trials) program, designed to improve access to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 2006
17 May 2013
© 2013 thepharmaletter.com